SCHEMBL13650560

SCHEMBL13650560

CCOC(=O)CCC1CCC(c2cccnc2)(N(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.43
OPRL1 P41146 4/20 0.43
ALDH1A1 P00352 5/20 0.42
GAA P10253 3/20 0.40
KDM4E B2RXH2 2/20 0.39
CASP1 P29466 2/20 0.39
MAPT P10636 1/20 0.39
CASP7 P55210 1/20 0.39
TBXAS1 P24557 3/20 0.39
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SLC22A1 O15245 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407202 0.89 OPRM1 (0.43) OPRM1OPRL1ALDH1A1GAAKDM4E
SCHEMBL13650545 0.86 OPRM1 (0.57) OPRM1OPRL1TDP1L3MBTL1SLC22A1
SCHEMBL3408534 0.80 OPRL1 (0.46) OPRM1OPRL1SLC6A2SLC6A4
SCHEMBL3410991 0.79 OPRM1 (0.44) OPRM1OPRL1SLC6A2SLC6A4
SCHEMBL13650562 0.77 OPRM1 (0.39) OPRM1OPRL1GAASLC6A2SLC6A4
SCHEMBL13657193 0.77 OPRL1 (0.43) OPRM1OPRL1SLC6A2SLC6A4
SCHEMBL3406596 0.76 OPRM1 (0.40) OPRM1OPRL1ALDH1A1SLC6A2SLC6A4
SCHEMBL13657194 0.76 OPRL1 (0.44) OPRM1OPRL1SLC6A2SLC6A4
SCHEMBL3408486 0.76 OPRL1 (0.44) OPRM1OPRL1GAA
SCHEMBL4114193 0.75 OPRL1 (0.48) OPRM1OPRL1SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253669-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253669-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 OPRM1 2798/4885OPRL1 2189/4885ALDH1A1 863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.